Immune Technologies

Immune Technology Corp is a biotechnology company specializing in the development and production of high-quality reagents for infectious disease research and vaccine development. The company offers an extensive catalog of over 1,000 recombinant viral proteins, including a comprehensive collection of influenza hemagglutinin (HA), neuraminidase (NA), and nucleoprotein (NP) antigens. In addition to its product portfolio, Immune Technology provides contract research services such as custom protein expression, antibody production, and assay development. Their expertise spans a wide range of viruses, including SARS-CoV-2, RSV, Ebola, and Zika, supporting global research efforts in virology and immunology. The company is a key supplier to academic, governmental, and industrial laboratories worldwide.